CA2675445C - Improved culture of stem cells - Google Patents

Improved culture of stem cells Download PDF

Info

Publication number
CA2675445C
CA2675445C CA2675445A CA2675445A CA2675445C CA 2675445 C CA2675445 C CA 2675445C CA 2675445 A CA2675445 A CA 2675445A CA 2675445 A CA2675445 A CA 2675445A CA 2675445 C CA2675445 C CA 2675445C
Authority
CA
Canada
Prior art keywords
culture
pluripotent stem
cells
agent
stem cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2675445A
Other languages
English (en)
French (fr)
Other versions
CA2675445A1 (en
Inventor
Veit Bergendahl
James A. Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39277243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2675445(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of CA2675445A1 publication Critical patent/CA2675445A1/en
Application granted granted Critical
Publication of CA2675445C publication Critical patent/CA2675445C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2675445A 2007-01-17 2008-01-17 Improved culture of stem cells Active CA2675445C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88074707P 2007-01-17 2007-01-17
US60/880,747 2007-01-17
PCT/US2008/051347 WO2008089351A1 (en) 2007-01-17 2008-01-17 Improved culture of stem cells

Publications (2)

Publication Number Publication Date
CA2675445A1 CA2675445A1 (en) 2008-07-24
CA2675445C true CA2675445C (en) 2014-11-04

Family

ID=39277243

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2675445A Active CA2675445C (en) 2007-01-17 2008-01-17 Improved culture of stem cells

Country Status (6)

Country Link
US (1) US7892830B2 (enExample)
JP (1) JP5419279B2 (enExample)
CA (1) CA2675445C (enExample)
GB (1) GB2458863B (enExample)
SE (1) SE0950586L (enExample)
WO (1) WO2008089351A1 (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4667241B2 (ja) * 2003-06-27 2011-04-06 旭化成株式会社 細胞分化抑制剤、これを用いた細胞培養方法、培養液及び培養された細胞株
WO2007026353A2 (en) 2005-08-29 2007-03-08 Technion Research & Development Foundation Ltd. Media for culturing stem cells
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US8129187B2 (en) 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
DK2733203T3 (en) 2006-08-02 2019-02-04 Technion Res & Dev Foundation PROCEDURES FOR EXPANSION OF EMBRYONAL STEM CELLS IN A SUSPENSION CULTURE
JP2008099662A (ja) * 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research 幹細胞の培養方法
JP2008307007A (ja) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
JP5951254B2 (ja) 2008-03-17 2016-07-13 ザ スクリプス リサーチ インスティテュート 人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
WO2009116840A2 (en) * 2008-03-21 2009-09-24 Industry-Academic Cooperation Foundation, Yonsei University Chemical reagents regulating stem cell fate
JP5346925B2 (ja) 2008-05-02 2013-11-20 国立大学法人京都大学 核初期化方法
EP2291511B1 (en) 2008-05-02 2017-06-21 Cellular Dynamics International, Inc. Method for production of mast cells from stem cells
US8648170B2 (en) 2008-09-19 2014-02-11 Wisconsin Alumni Research Foundation Peptide-presenting surfaces for long-term culture of pluripotent cells
MX2011005288A (es) * 2008-11-20 2011-06-01 Centocor Ortho Biotech Inc Celulas madre pluripotentes en microportadores.
SG172160A1 (en) 2008-12-17 2011-07-28 Scripps Research Inst Generation and maintenance of stem cells
US8642334B2 (en) 2009-02-17 2014-02-04 Memorial Sloan Kettering Cancer Center Methods of neural conversion of human embryonic stem cells
EP2398897B1 (en) * 2009-02-20 2017-06-28 Cellular Dynamics International, Inc. Methods and compositions for the differentiation of stem cells
SG174471A1 (en) * 2009-03-20 2011-10-28 Agency Science Tech & Res Culture of pluripotent and multipotent cells on microcarriers
US8193235B2 (en) * 2009-06-12 2012-06-05 University Of Kansas Compositions and methods for establishing and maintaining stem cells in an undifferentiated state
MX389666B (es) * 2009-10-16 2025-03-19 Scripps Research Inst Induccion de celulas pluripotentes.
EP3255142A1 (en) * 2009-10-19 2017-12-13 Cellular Dynamics International, Inc. Cardiomyocyte production
KR101775926B1 (ko) * 2009-11-04 2017-09-07 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 화학 물질을 이용한 에피솜 재프로그래밍
CN102712896A (zh) * 2009-11-06 2012-10-03 Rnl生物技术株式会社 用于增殖毛囊干细胞的方法
WO2011058558A2 (en) 2009-11-12 2011-05-19 Technion Research & Development Foundation Ltd. Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
CA2782577A1 (en) * 2009-12-02 2011-06-09 Research Development Foundation Selection of stem cell clones with defined differentiation capabilities
CA2800498C (en) 2010-03-31 2021-11-16 The Scripps Research Institute Reprogramming cells
WO2011159726A2 (en) 2010-06-14 2011-12-22 The Scripps Research Institute Reprogramming of cells to a new fate
AU2011290123B2 (en) * 2010-08-09 2016-11-10 Takeda Pharmaceutical Company Limited Method of producing pancreatic hormone-producing cells
EP3056198A2 (en) * 2010-09-16 2016-08-17 MSP Co., Ltd Use of compounds for inducing differentiation of mesenchymal stem cells to chondrocytes
US9181529B2 (en) 2010-10-19 2015-11-10 Cellular Dynamics International, Inc. Titration of differentiation medium components
US9732319B2 (en) 2010-12-22 2017-08-15 Fate Therapeutics, Inc. Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
US9334523B2 (en) * 2011-02-14 2016-05-10 Life Technologies Corporation Substrates and methods for staining live stem cells
CA2831609C (en) 2011-03-30 2019-06-11 Cellular Dynamics International, Inc. Priming of pluripotent stem cells for neural differentiation
WO2013009825A1 (en) 2011-07-11 2013-01-17 Cellular Dynamics International, Inc. Methods for cell reprogramming and genome engineering
AU2012332269B2 (en) 2011-11-04 2018-05-31 Memorial Sloan-Kettering Cancer Center Midbrain dopamine (DA) neurons for engraftment
US10238755B2 (en) 2011-11-30 2019-03-26 The Wistar Institute Of Anatomy And Biology Methods and compositions for regulation of cell aging, carcinogenesis and reprogramming
WO2014165663A1 (en) 2013-04-03 2014-10-09 Cellular Dynamics International, Inc. Methods and compositions for culturing endoderm progenitor cells in suspension
JP6756610B2 (ja) 2013-04-26 2020-09-16 メモリアル スローン ケタリング キャンサー センター 多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞
CN120536341A (zh) 2014-03-04 2025-08-26 菲特治疗公司 改良的重编程方法和细胞培养平台
US9694036B2 (en) 2014-03-21 2017-07-04 Cellular Dynamics International, Inc. Production of midbrain dopaminergic neurons and methods for the use thereof
US10444227B2 (en) 2014-08-19 2019-10-15 FUJIFILM Cellular Dynamics, Inc. Neural networks formed from cells derived from pluripotent stem cells
JP6581655B2 (ja) 2014-10-14 2019-09-25 フジフィルム セルラー ダイナミクス，インコーポレイテッド 多能性幹細胞由来ケラチノサイトの生成およびケラチノサイト培養の維持
CN117737124A (zh) 2015-10-16 2024-03-22 菲特治疗公司 用于诱导和维护基态多能性的平台
AU2016342015B2 (en) 2015-10-21 2021-07-01 Indiana University Research And Technology Corporation Derivation of human skin organoids from pluripotent stem cells
CN108291197B (zh) 2015-10-21 2022-09-16 印第安纳大学研究与技术公司 生成人内耳感觉上皮和感觉神经元的方法
KR102929174B1 (ko) 2015-10-30 2026-02-20 더 리전츠 오브 더 유니버시티 오브 캘리포니아 줄기세포로부터 t-세포를 생산하는 방법 및 상기 t-세포를 이용한 면역치료 방법
US20190127707A1 (en) * 2016-03-30 2019-05-02 Kyowa Hakko Bio Co., Ltd. Medium for culturing naive pluripotent stem cells and method for culturing pluripotent stem cells
AU2017313065B2 (en) 2016-08-16 2021-06-24 Fujifilm Cellular Dynamics Inc. Methods for differentiating pluripotent cells
US11767508B2 (en) 2017-07-24 2023-09-26 Wisconsin Alumni Research Foundation Methods and culture substrates for controlled induction of biomimetic neural tissues comprising singular rosette structures
JP7669266B2 (ja) 2018-08-31 2025-04-28 ウィスコンシン アラムニ リサーチ ファンデーション 動脈内皮細胞を播種した血管移植片の生成
EP4319876A1 (en) 2021-04-07 2024-02-14 Fujifilm Cellular Dynamics, Inc. Dopaminergic precursor cells and methods of use
AU2022376962A1 (en) 2021-10-29 2024-04-18 FUJIFILM Cellular Dynamics, Inc. Dopaminergic neurons comprising mutations and methods of use thereof
WO2025097051A1 (en) 2023-11-03 2025-05-08 Axent Biosciences Inc. Thermoreversible polymers with improved stability and methods and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
PT885888E (pt) * 1996-02-02 2003-12-31 Western Therapeutics Inst D Derivados e farmacos de isoquinolina
PT956865E (pt) * 1996-08-12 2007-07-30 Mitsubishi Pharma Corp Medicamentos compreendendo inibidores da rho cinase.
US7439064B2 (en) * 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
US20020009713A1 (en) * 2000-05-11 2002-01-24 Miller Freda D. Methods for identifying modulators of neuronal growth
WO2003080649A2 (en) * 2002-03-20 2003-10-02 Regents Of The University Of Minnesota Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
EP1601759A4 (en) * 2003-03-07 2007-02-14 Gamida Cell Ltd EXPANSION OF RENEWABLE STEM CELL POPULATIONS USING PI-3 KINASE MODULATORS
US7829332B2 (en) * 2004-02-13 2010-11-09 Cornell Research Foundation, Inc. Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom
JP4576545B2 (ja) * 2004-05-27 2010-11-10 独立行政法人理化学研究所 羊膜由来因子による胚性幹細胞の培養方法
US8187878B2 (en) 2004-08-13 2012-05-29 University Of Georgia Research Foundation, Inc. Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors
BRPI0514641A (pt) * 2004-09-08 2008-06-17 Wisconsin Alumni Res Found cultivação das células tronco embriÈnica humana
BRPI0514778B1 (pt) * 2004-09-08 2018-07-10 Wisconsin Alumni Research Foundation Meio para cultivar células tronco embrionárias
US7641897B2 (en) * 2004-11-23 2010-01-05 The Board Of Trustees Of The Leland Stanford Junior University Feeder layer and serum independent embryonic stem cells
ITVA20060041A1 (it) 2006-07-05 2008-01-06 Dialectica Srl Uso di composti derivati amminotiazolici, di loro composizioni farmaceutiche, nel trattamento di malattie caratterizzate dalla anormale repressione della trascrizione genica, particolarmente il morbo di huntington
BRPI0713187A2 (pt) * 2006-07-20 2012-10-16 Mehmet Kahraman método de inibir rho-quinase, método de tratamento de doença mediada por rho-quinase, composto e composição farmacêutica
JP2008099662A (ja) 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research 幹細胞の培養方法

Also Published As

Publication number Publication date
JP5419279B2 (ja) 2014-02-19
US20080171385A1 (en) 2008-07-17
GB0914193D0 (en) 2009-09-16
JP2010516255A (ja) 2010-05-20
SE0950586L (sv) 2009-08-13
GB2458863A (en) 2009-10-07
WO2008089351A1 (en) 2008-07-24
US7892830B2 (en) 2011-02-22
GB2458863B (en) 2011-10-12
CA2675445A1 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
US7892830B2 (en) Clonal culture of human pluripotent stem cells
US11680246B2 (en) Ex vivo proliferation of epithelial cells
JP7635119B2 (ja) 細胞培養のための組成物および方法
RU2555538C2 (ru) Культура плюрипотентных стволовых клеток на микроносителях
US10100285B2 (en) Ex vivo proliferation of epithelial cells
EP3438248A1 (en) Naïve pluripotential stem cell culturing medium and pluripotential stem cell culturing method
WO2014078414A1 (en) Chemically defined production of cardiomyocytes from pluripotent stem cells
CN111684058B (zh) 从多能干细胞向肠上皮细胞的分化诱导方法
CN102428172A (zh) 多潜能和多能细胞在微载体上的培养
US20220267736A1 (en) Pluripotent stem cell aggregation suppressor
US20240384232A1 (en) Clinical-grade therapeutic progenitors generated from tankyrase/parp-inhibited pluripotent stem cell banks
US20220282219A1 (en) Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells
KR20250038692A (ko) At2 세포로 분화시키는 방법
Kempf et al. Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells
JP2021126066A (ja) 細胞凝集抑制剤
De Los Angeles et al. ERK-independent African Green monkey pluripotent stem cells in a putative chimera-competent state
CN115516084A (zh) T细胞祖细胞的制造方法
JP2023106639A (ja) 内耳前駆細胞の製造方法、内耳有毛細胞の製造方法、薬剤の評価方法、及び内耳細胞分化誘導用組成物
Chen et al. Effect of dual‐specificity protein phosphatase 5 on pluripotency maintenance and differentiation of mouse embryonic stem cells
Zandi et al. Optimization of buffalo (Bubalus bubalis) embryonic stem cell culture system
JP2023106640A (ja) 内耳有毛細胞の製造方法、薬剤の評価方法、及び細胞分化誘導用組成物
Cowan Characterisation of a novel pluripotent stem cell survival compound

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130115

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250113

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250113

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250113

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - STANDARD

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251203

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251203